Importance of blood pressure lowering in patients with direct oral anticoagulant-associated intracerebral haemorrhage in the acute phase and for secondary prevention
European Stroke Journal · 2025
DOI: 10.1177/23969873231208544 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift European Stroke Journal, 2025. Verfasst von Adrian R Parry-Jones und 5 weiteren Autor:innen. Beteiligte Einrichtung: Geoffrey Jefferson Brain Research Centre, Manchester Academic Health Science Centre, Northern Care Alliance & University of Manchester, Manchester, U…. Hauptthemen laut MEDLINE: Cerebral Hemorrhage, Anticoagulants, Secondary Prevention, Blood Pressure. Die Arbeit nennt 83 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Purpose
Intracerebral haemorrhage (ICH) is an important complication of direct oral anticoagulation (DOAC) therapy, where risks and prognosis are potentially modified by effective blood pressure (BP) control, both in the acute phase and for secondary prevention. Herein, we review BP management in the context of general anticoagulation associated ICH and specifically in DOAC-ICH, considering current evidence and highlighting outstanding questions.
Method
Narrative review.
Findings
Pooled analyses of major trials of BP lowering in acute ICH patients without anticoagulants demonstrate a reduction in the risk of haematoma expansion. As anticoagulant-associated ICH patients tend to be older, have more co-morbidities, and larger haematomas at baseline with a greater risk of expansion, the risks and benefits of intensive BP lowering treatment might both be higher. Small observational studies of DOAC-ICH patients suggest that lower achieved BP is associated with less expansion, lower mortality, and better functional outcomes. Care bundles including both anticoagulant reversal and intensive BP lowering might reduce the risk of death and disability in DOAC-ICH. Optimal control of BP in survivors of ICH reduces the risk of both ischaemic and haemorrhagic stroke but whether this modulates the risks and benefits of restarting a DOAC is unknown.
Discussion
Limited evidence suggests that BP should be well managed in DOAC-ICH patients, in the same way as ICH patients not on anticoagulants, both in the hyperacute phase and for secondary prevention. Hypothetical differences in the effects of BP lowering treatment in DOAC-ICH need to be tested in clinical trials.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Geoffrey Jefferson Brain Research Centre, Manchester Academic Health Science Centre, Northern Care Alliance & University of Manchester, Manchester, UK.
- Division of Cardiovascular Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK.
- Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK.
- Department of Clinical Neurosciences, NHS Lothian, Edinburgh, UK.
- Department of Neurology, Stroke Unit, Oslo University Hospital, Oslo, Norway.
- The Norwegian Air Ambulance Foundation, Oslo, Norway.
ORCID-Profile: Adrian R Parry-Jones, Tom J Moullaali, Else C Sandset, Craig S Anderson, Thorsten Steiner
Zitieren
APA
Parry-Jones, A. R., Moullaali, T. J., Sandset, E. C., Qureshi, A. I., Anderson, C. S., & Steiner, T. (2025). Importance of blood pressure lowering in patients with direct oral anticoagulant-associated intracerebral haemorrhage in the acute phase and for secondary prevention. European Stroke Journal. https://doi.org/10.1177/23969873231208544
Vancouver
Parry-Jones AR, Moullaali TJ, Sandset EC, Qureshi AI, Anderson CS, Steiner T. Importance of blood pressure lowering in patients with direct oral anticoagulant-associated intracerebral haemorrhage in the acute phase and for secondary prevention. European Stroke Journal. 2025. doi:10.1177/23969873231208544
BibTeX
@article{ParryJones2025,
author = {Parry-Jones, Adrian R and Moullaali, Tom J and Sandset, Else C and Qureshi, Adnan I and Anderson, Craig S and Steiner, Thorsten},
title = {Importance of blood pressure lowering in patients with direct oral anticoagulant-associated intracerebral haemorrhage in the acute phase and for secondary prevention},
journal = {European Stroke Journal},
year = {2025},
doi = {10.1177/23969873231208544}
}
EUVIMED